Tuesday, August 04, 2020

Siriraj to produce first mite allergen vaccine in Asean

Dec 11. 2019
Facebook Twitter

By The Nation

The Siriraj Dust Mite Centre for Services and Research recently said it would produce dust mite on semi-industrial scale which will further be used as the initial substance in mite allergen vaccine, after more than 20 years of research.

They were granted mite allergen vaccine certification by the Thai Food and Drug Administration on October 31. The mite centre now provides the know-how to the private sector and aims to become the central hub for R&D on dust mite allergy in the Asean region to produce more mite allergen-friendly products or suggest improvement or advice to the private sector or nongovernmental organisations, such as anti-mite mattress and air-conditioning.

Prof Dr Anchalee Tungtrongchitr, the director, said that “Another service provided here is anti-mite effectiveness in product testing, to protect consumers from pseudo-science-backed products.”

Facebook Twitter
More in Lifestyle
Editor’s Picks
Top News